Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.56 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.56 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.56 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.55 |
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.52 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.52 |
| ▸ | CALCR | P30988 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31014196 | 0.97 | MAPK8 (0.60) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL30248619 | 0.97 | MAPK8 (0.59) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL25028436 | 0.96 | MAPK8 (0.54) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL25028618 | 0.96 | KEAP1 (0.54) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL31014198 | 0.95 | MAPK8 (0.56) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL25027391 | 0.95 | MAPK8 (0.52) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL30248579 | 0.94 | MAPK8 (0.63) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL25027372 | 0.93 | MAPK8 (0.56) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL25027370 | 0.93 | MAPK8 (0.55) | MAPK8MAPK9MAPK10KEAP1NMUR2 | |
| SCHEMBL25028160 | 0.93 | MAPK8 (0.52) | MAPK8MAPK9MAPK10KEAP1NMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116829169-B | Synthetic peptides, compositions and uses thereof | 深圳市维琪科技股份有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-20240352069-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | SHENZHEN WINKEY TECHNOLOGY CO., LTD. (CN) | 2024-10-24 | — | — | US | claimed |
| EP-4385516-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Shenzhen Winkey Technology Co., Ltd. (CN) | 2024-06-19 | — | — | EP | claimed |
| CN-116829169-B | Synthetic peptides, compositions and uses thereof | 深圳市维琪科技股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-20240352069-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | SHENZHEN WINKEY TECHNOLOGY CO., LTD. (CN) | 2024-10-24 | — | — | US | disclosed |
| EP-4385516-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Shenzhen Winkey Technology Co., Ltd. (CN) | 2024-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240352069-A1 | SYNTHETIC PEPTIDE, AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | VIP, MC1R, PROKR1 | MAPK8 1840/4885MAPK9 934/4885MAPK10 1019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.